Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03008187
Title SEL24 in Patients With AML
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Selvita S.A.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | ESP

Facility Status City State Zip Country Details
Northside Hospital Atlanta Georgia 30342 United States Details
Cleveland Clinic, Taussig Cancer Institute Cleveland Ohio 44195 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola Italy Details
Istituto Clinico Humanitas Milano Italy Details
ASST Monza - Ospedale San Gerardo Monza Italy Details
Institute of Haematology and Blood Transfusion Warsaw Poland Details
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Oddzial Hematologii z Pododdzialem Chemioterapi Łódź Poland Details
Institut Català d'Oncologia Badalona Spain Details
Hospital 12 de Octubre Madrid Spain Details
Hospital Universitari i Politecnic La Fe Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field